Financhill
Buy
54

BMRN Quote, Financials, Valuation and Earnings

Last price:
$60.16
Seasonality move :
5.52%
Day range:
$59.24 - $61.79
52-week range:
$50.76 - $73.51
Dividend yield:
0%
P/E ratio:
22.91x
P/S ratio:
3.88x
P/B ratio:
1.94x
Volume:
5.3M
Avg. volume:
3.4M
1-year change:
-7.74%
Market cap:
$11.7B
Revenue:
$2.8B
EPS (TTM):
$2.67

Earnings Data

Next earnings date for BMRN
Feb 19
2026
Most recent earnings per share
-$0.16
Missed by $0.50
(Oct 27/2025)
Consensus Estimate
$0.34
(Oct 27/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

BMRN Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
02/19/2026 Q4 $822.1M -- -- $0.93 --
10/27/2025 Q3 $780.4M $786.8M -$0.16 $0.34 -$0.50
08/04/2025 Q2 $761.7M $827.5M $1.23 $1.03 $0.20
05/01/2025 Q1 $738.7M $732.6M $0.95 $0.95 $0.00
02/19/2025 Q4 $711M $738.2M $0.64 $0.74 -$0.09
10/29/2024 Q3 $703.3M $742.4M $0.55 $0.79 -$0.24
08/05/2024 Q2 $664M $712M $0.55 $0.60 -$0.05
04/24/2024 Q1 $651.8M $648.8M $0.46 $0.60 -$0.14
02/22/2024 Q4 $636.9M $646.2M $0.11 $0.45 -$0.34
11/01/2023 Q3 -- -- $0.21 $0.48 -$0.27
07/31/2023 Q2 -- -- $0.29 $0.47 -$0.18
04/26/2023 Q1 -- -- $0.27 $0.40 -$0.13
02/27/2023 Q4 -- -- -$0.00 $0.39 -$0.39
10/26/2022 Q3 -- -- -$0.04 $0.43 -$0.47
08/03/2022 Q2 -- -- $0.15 $0.53 -$0.38
04/27/2022 Q1 -- -- $0.63 $0.46 $0.18
02/23/2022 Q4 -- -- -$0.32 -$0.01 -$0.31
10/27/2021 Q3 -- -- -$0.20 $0.09 -$0.29
07/28/2021 Q2 -- -- $0.07 $0.25 -$0.18
04/29/2021 Q1 -- -- $0.09 $0.30 -$0.21
02/25/2021 Q4 -- -- $0.12 $0.18 -$0.06
11/05/2020 Q3 -- -- $4.01 $0.26 $3.75
08/04/2020 Q2 -- -- -$0.16 $0.20 -$0.36
04/30/2020 Q1 -- -- $0.44 $0.33 $0.11
02/26/2020 Q4 -- -- $0.08 $0.24 -$0.16
10/23/2019 Q3 -- -- $0.30 $0.34 -$0.04
08/01/2019 Q2 -- -- -- $0.19 --
04/25/2019 Q1 -- -- -- $0.10 --
02/21/2019 Q4 -- -- -- $0.12 --
10/25/2018 Q3 -- -- -- $0.15 --
08/02/2018 Q2 -- -- -- -- --
04/25/2018 Q1 -- -- -- -- --
02/22/2018 Q4 -- -- -- -- --
10/26/2017 Q3 -- -- -- -- --
08/02/2017 Q2 -- -- -- -- --
05/04/2017 Q1 -- -- -- -- --
02/23/2017 Q4 -- -- -- -- --
10/27/2016 Q3 -- -- -- -- --
08/04/2016 Q2 -- -- -- -- --
04/12/2016 Q1 -- -- -- -- --
02/25/2016 Q4 -- -- -- -- --

BioMarin Pharmaceutical, Inc. Earnings Questions

  • How Much did BioMarin Pharmaceutical, Inc. Generate in Revenue Last Quarter?

    BioMarin Pharmaceutical, Inc. reported $786.8M worth of top line sales in its most recent quarter.

  • Did BioMarin Pharmaceutical, Inc. Beat Earnings Last Quarter?

    BioMarin Pharmaceutical, Inc. announced earnings per share of -$0.16 which represents a miss of analyst forecast a $0.34 per share.

  • Is BioMarin Pharmaceutical, Inc. Profitable?

    BioMarin Pharmaceutical, Inc. reported $641.8M that represents $3.34 per share over the last quarter.

  • What is the Analyst Consensus for BioMarin Pharmaceutical, Inc. EPS Next Year?

    BioMarin Pharmaceutical, Inc.'s earnings are forecast to grow from $2.21 per share to $3.30 per share next year representing an increase of 61.94%.

  • When is BioMarin Pharmaceutical, Inc.'s Earnings Date?

    BioMarin Pharmaceutical, Inc.'s next earnings date is February 19, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
59
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
53
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 36x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
60
AAOI alert for Dec 24

Applied Optoelectronics, Inc. [AAOI] is up 5.1% over the past day.

Buy
85
HUT alert for Dec 24

Hut 8 Corp. [HUT] is up 0.65% over the past day.

Buy
63
GPCR alert for Dec 24

Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock